首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3476364篇
  免费   246434篇
  国内免费   11022篇
耳鼻咽喉   46457篇
儿科学   113550篇
妇产科学   96242篇
基础医学   491912篇
口腔科学   96411篇
临床医学   324029篇
内科学   678599篇
皮肤病学   79773篇
神经病学   287974篇
特种医学   130237篇
外国民族医学   1048篇
外科学   506949篇
综合类   72307篇
现状与发展   6篇
一般理论   1357篇
预防医学   278560篇
眼科学   77897篇
药学   254176篇
  12篇
中国医学   7679篇
肿瘤学   188645篇
  2021年   27968篇
  2019年   29143篇
  2018年   40975篇
  2017年   30970篇
  2016年   35125篇
  2015年   39723篇
  2014年   54539篇
  2013年   83007篇
  2012年   111773篇
  2011年   118197篇
  2010年   70661篇
  2009年   66454篇
  2008年   109201篇
  2007年   115666篇
  2006年   117074篇
  2005年   112410篇
  2004年   107703篇
  2003年   103715篇
  2002年   100161篇
  2001年   159986篇
  2000年   164180篇
  1999年   138653篇
  1998年   40541篇
  1997年   35937篇
  1996年   35950篇
  1995年   34676篇
  1994年   31979篇
  1993年   30074篇
  1992年   108710篇
  1991年   105138篇
  1990年   101910篇
  1989年   98077篇
  1988年   90082篇
  1987年   88351篇
  1986年   83362篇
  1985年   79661篇
  1984年   59591篇
  1983年   50861篇
  1982年   30300篇
  1979年   53247篇
  1978年   37788篇
  1977年   31683篇
  1976年   29958篇
  1975年   31551篇
  1974年   37727篇
  1973年   36111篇
  1972年   33714篇
  1971年   31351篇
  1970年   29072篇
  1969年   27531篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
14.
15.
16.
随着婴儿潮、人口老龄化及新技术的广泛应用,人们对听力保健的需求显著增加。在美国,听力保健服务由助听设备专员、耳鼻喉科医生和听力师3类人员提供,其中听力师提供除医疗、手术外宽泛的听力保健服务。美国的听力保健服务体系及听力师教育体系经历了一个渐进的过程:20年前对从业人员的学历要求是听力学硕士,随着对服务质量要求的提高和服务范围的扩大,美国听力师逐渐要求专业博士学位(Au.D),毕业后还需3~4年的专门教育才能成为一名听力师。听力师教育有统一的标准,大学课程要通过听力教育认证委员会(the Accreditation Commission for Audiology Education, ACAE)或学术认证委员会(the Council on Academic Accreditation,CAA)的多程序严格的认证才能被承认。美国听力师需求存在巨大缺口,但是各国听力学教育标准不统一及听力师收入与教育投资不匹配,阻碍了更多的人进入这一领域。美国试图通过改变教育模式,降低教育成本及革新教学方法等改善听力师教育状况,但是听力师教育体系远未完善。  相似文献   
17.
18.
Abstract

Objectives: This study examined word use as an indicator of interpersonal positive reframing in daily conversations of couples coping with breast cancer and as a predictor of stress.

Design: The Electronically Activated Recorder (EAR) and Linguistic Inquiry and Word Count (LIWC) were used to examine naturally occurring word use conceptually linked to positive reframing (positive emotion, negative emotion, and cognitive processing words).

Sample: Fifty-two couples coping with breast cancer.

Methods: Couples wore the EAR, a device participants wear, that audio-recorded over one weekend (>16,000 sound files), and completed self-reports of positive reframing (COPE) and stress (Perceived Stress Scale). LIWC, a software program, measured word use.

Findings: Both partners’ word use (i.e., positive emotion and cognitive processing words) was associated with their own reported positive reframing, and spouses’ word use was also indicative of patients’ positive reframing. Results also revealed that, in general, words indicating positive reframing predicted lower levels of stress.

Conclusions: Findings supported the hypothesis that partners—and particularly spouses of breast cancer patients—may assist each other’s coping by positively reframing the cancer experience and other negative experiences in conversation.  相似文献   
19.

Background

Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.

Objectives

To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.

Methods

Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.

Results

Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.

Conclusions

These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study.  相似文献   
20.

Aims

To examine the influence of pre-existing psychiatric disorder on the choice of treatment in patients with gynaecological cancer.

Materials and methods

The analyses were based on all patients who underwent surgical treatment for endometrial, ovarian or cervical cancer who were registered in the Danish Gynecological Cancer Database in the years 2007–2014 (3059 patients with ovarian cancer, 5100 patients with endometrial cancer and 1150 with cervical cancer). Logistic regression model and Cox regression model, adjusted for relevant confounders, were used to estimate the effect of pre-existing psychiatric disorder on the course of cancer treatment. Our outcomes were (i) presurgical oncological treatment, (ii) macroradical surgery for patients with ovarian cancer, (iii) radiation/chemotherapy within 30 days and 100 days after surgery and (iv) time from surgery to first oncological treatment.

Results

In the group of patients with ovarian cancer, more patients with a psychiatric disorder received macroradical surgery versus patients without a psychiatric disorder, corresponding to an adjusted odds ratio of 1.24 (95% confidence interval 0.62–2.41) and the chance for having oncological treatment within 100 days was odds ratio = 1.26 (95% confidence interval 0.77–2.10). As for patients with endometrial cancer, all outcome estimates were close to unity. The adjusted odds ratio for oncological treatment within 30 days after surgery in patients with cervical cancer with a history of psychiatric disorder was 0.20 (95% confidence interval 0.03–1.54).

Conclusions

We did not find any significant differences in the treatment of ovarian and endometrial cancer in patients with pre-existing psychiatric diagnoses. When it comes to oncological treatment, we suggest that increased attention should be paid to patients with cervical cancer having a pre-existing psychiatric diagnosis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号